Cryptogenic cirrhosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:


== Overview ==
== Overview ==
Cryptogenic cirrhosis is defined as cirrhosis of unknown origin. It is a diagnosis of exclusion and is only made after extensive investigative workup when the underlying cause of cirrhosis remains elusive. The cause of this condition is, by definition, unknown; however, there are correlations suggesting that metabolic dysfunction-associated steatohepatitis (MASH) plays a significant role {{cite_web}}. Advances in investigative methods, understanding of liver disease, and acknowledgment of metabolic dysfunction-associated steatohepatitis (MASH) as a plausible cause have led to a signifcant decrease in the use of this term[1],  
Cryptogenic cirrhosis is defined as cirrhosis of unknown origin. It is a diagnosis of exclusion and is only made after extensive investigative workup when the underlying cause of cirrhosis remains elusive. The cause of this condition is, by definition, unknown; however, there are correlations suggesting that metabolic dysfunction-associated steatohepatitis (MASH) plays a significant role . Advances in investigative methods, understanding of liver disease, and acknowledgment of metabolic dysfunction-associated steatohepatitis (MASH) as a plausible cause have led to a signifcant decrease in the use of this term.  


==Historical Perspective==
==Historical Perspective==

Revision as of 17:19, 20 April 2024

WikiDoc Resources for Cryptogenic cirrhosis

Articles

Most recent articles on Cryptogenic cirrhosis

Most cited articles on Cryptogenic cirrhosis

Review articles on Cryptogenic cirrhosis

Articles on Cryptogenic cirrhosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cryptogenic cirrhosis

Images of Cryptogenic cirrhosis

Photos of Cryptogenic cirrhosis

Podcasts & MP3s on Cryptogenic cirrhosis

Videos on Cryptogenic cirrhosis

Evidence Based Medicine

Cochrane Collaboration on Cryptogenic cirrhosis

Bandolier on Cryptogenic cirrhosis

TRIP on Cryptogenic cirrhosis

Clinical Trials

Ongoing Trials on Cryptogenic cirrhosis at Clinical Trials.gov

Trial results on Cryptogenic cirrhosis

Clinical Trials on Cryptogenic cirrhosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cryptogenic cirrhosis

NICE Guidance on Cryptogenic cirrhosis

NHS PRODIGY Guidance

FDA on Cryptogenic cirrhosis

CDC on Cryptogenic cirrhosis

Books

Books on Cryptogenic cirrhosis

News

Cryptogenic cirrhosis in the news

Be alerted to news on Cryptogenic cirrhosis

News trends on Cryptogenic cirrhosis

Commentary

Blogs on Cryptogenic cirrhosis

Definitions

Definitions of Cryptogenic cirrhosis

Patient Resources / Community

Patient resources on Cryptogenic cirrhosis

Discussion groups on Cryptogenic cirrhosis

Patient Handouts on Cryptogenic cirrhosis

Directions to Hospitals Treating Cryptogenic cirrhosis

Risk calculators and risk factors for Cryptogenic cirrhosis

Healthcare Provider Resources

Symptoms of Cryptogenic cirrhosis

Causes & Risk Factors for Cryptogenic cirrhosis

Diagnostic studies for Cryptogenic cirrhosis

Treatment of Cryptogenic cirrhosis

Continuing Medical Education (CME)

CME Programs on Cryptogenic cirrhosis

International

Cryptogenic cirrhosis en Espanol

Cryptogenic cirrhosis en Francais

Business

Cryptogenic cirrhosis in the Marketplace

Patents on Cryptogenic cirrhosis

Experimental / Informatics

List of terms related to Cryptogenic cirrhosis

For patient information, click Cryptogenic Cirrhosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Imam Ali Shah, MBBS [2]

Synonyms and keywords: Idiopathic Cirrhosis

Overview

Cryptogenic cirrhosis is defined as cirrhosis of unknown origin. It is a diagnosis of exclusion and is only made after extensive investigative workup when the underlying cause of cirrhosis remains elusive. The cause of this condition is, by definition, unknown; however, there are correlations suggesting that metabolic dysfunction-associated steatohepatitis (MASH) plays a significant role . Advances in investigative methods, understanding of liver disease, and acknowledgment of metabolic dysfunction-associated steatohepatitis (MASH) as a plausible cause have led to a signifcant decrease in the use of this term.

Historical Perspective

Classification

Pathophysiology

Genetics

Associated Conditions

Gross Pathology

Microscopic Pathology

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal / Ortho No underlying causes
Neurologic No underlying causes
Nutritional / Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Opthalmologic No underlying causes
Overdose / Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal / Electrolyte No underlying causes
Rheum / Immune / Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Dental No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

  • A...
  • Z...

Make sure that each diagnosis is linked to a page.

Differentiating type page name here from other Diseases

Epidemiology and Demographics

Age

Gender

Race

Developed Countries

Developing Countries

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

If available, the diagnostic criteria are provided here.

History

A directed history should be obtained to ascertain

Symptoms

"Type symptom here" is pathognomonic of the "type disease name here".

"Type non specific symptoms" may be present.

Past Medical History

Family History

Social History

Occupational

Alcohol

The frequency and amount of alcohol consumption should be characterized.

Drug Use

Smoking

Allergies

Physical Examination

Appearance of the Patient

Vital Signs

Skin

Head

Eyes

Ear

Nose

Mouth

Throat

Heart

Lungs

Abdomen

Extremities

Neurologic

Genitals

Other

Laboratory Findings

Electrolyte and Biomarker Studies

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Pharmacotherapy

Acute Pharmacotherapies

Chronic Pharmacotherapies

Surgery and Device Based Therapy

Indications for Surgery

Pre-Operative Assessment

Post-Operative Management

Transplantation

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

References